BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang H, Wu D, Xu D, Yu H, Zhao Z, Ma D, Jin J. Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma. Int J Biol Sci 2017;13:701-11. [PMID: 28655996 DOI: 10.7150/ijbs.17534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Qiao X, Wang J, Yang J, Yang C, Qiao Y, Guan Y, Wen A, Jiang L. Amelioration of DMH-induced colon cancer by eupafolin through the reprogramming of apoptosis-associated p53/Bcl2/Bax signaling in rats. Eur J Inflamm 2022;20:205873922110697. [DOI: 10.1177/20587392211069771] [Reference Citation Analysis]
2 Juaid N, Amin A, Abdalla A, Reese K, Alamri Z, Moulay M, Abdu S, Miled N. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. Int J Mol Sci 2021;22:10774. [PMID: 34639131 DOI: 10.3390/ijms221910774] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
3 Borgo J, Laurella LC, Martini F, Catalán CAN, Sülsen VP. Stevia Genus: Phytochemistry and Biological Activities Update. Molecules 2021;26:2733. [PMID: 34066562 DOI: 10.3390/molecules26092733] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Wei J, Zhang X, Pan H, He S, Yuan B, Liu Q, Zhang J, Ding Y. Eupafolin inhibits breast cancer cell proliferation and induces apoptosis by inhibiting the PI3K/Akt/mTOR pathway. Oncol Lett 2021;21:332. [PMID: 33692864 DOI: 10.3892/ol.2021.12593] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Sbenati RM, Zaraei SO, El-Gamal MI, Anbar HS, Tarazi H, Zoghbor MM, Mohamood NA, Khakpour MM, Zaher DM, Omar HA, Alach NN, Shehata MK, El-Gamal R. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. Eur J Med Chem 2021;210:113081. [PMID: 33310290 DOI: 10.1016/j.ejmech.2020.113081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chen X, Yao Z, Peng X, Wu L, Wu H, Ou Y, Lai J. Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway. Mol Med Rep 2020;22:5135-44. [PMID: 33173992 DOI: 10.3892/mmr.2020.11637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
7 Berenda J, Smöch C, Stadlbauer C, Mittermair E, Taxauer K, Huttary N, Krupitza G, Krenn L. Flavonoids Distinctly Stabilize Lymph Endothelial- or Blood Endothelial Disintegration Induced by Colon Cancer Spheroids SW620. Molecules 2020;25:E2066. [PMID: 32365473 DOI: 10.3390/molecules25092066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hsiao YH, Lin CW, Wang PH, Hsin MC, Yang SF. The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer. Integr Cancer Ther 2019;18:1534735419861693. [PMID: 31271066 DOI: 10.1177/1534735419861693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
9 Fan X, Tao J, Cai Z, Fredimoses M, Wu J, Jiang Z, Zhang K, Li S. Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase. Front Pharmacol 2019;10:1248. [PMID: 31708778 DOI: 10.3389/fphar.2019.01248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
10 El-Aarag B, Khairy A, Khalifa SAM, El-Seedi HR. Protective Effects of Flavone from Tamarix aphylla against CCl4-Induced Liver Injury in Mice Mediated by Suppression of Oxidative Stress, Apoptosis and Angiogenesis. Int J Mol Sci 2019;20:E5215. [PMID: 31640181 DOI: 10.3390/ijms20205215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases. Oxid Med Cell Longev 2018;2018:8394818. [PMID: 29507653 DOI: 10.1155/2018/8394818] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]